Literature DB >> 22907116

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

Sung R Choi1, Owain W Howell, Daniele Carassiti, Roberta Magliozzi, Djordje Gveric, Paolo A Muraro, Richard Nicholas, Federico Roncaroli, Richard Reynolds.   

Abstract

The primary progressive form of multiple sclerosis is characterized by accrual of neurological dysfunction from disease onset without remission and it is still a matter of debate whether this disease course results from different pathogenetic mechanisms compared with secondary progressive multiple sclerosis. Inflammation in the leptomeninges has been identified as a key feature of secondary progressive multiple sclerosis and may contribute to the extensive cortical pathology that accompanies progressive disease. Our aim was to investigate the extent of perivascular and meningeal inflammation in primary progressive multiple sclerosis in order to understand their contribution to the pathogenetic mechanisms associated with cortical pathology. A comprehensive immunohistochemical analysis was performed on post-mortem brain tissue from 26 cases with primary progressive multiple sclerosis. A variable extent of meningeal immune cell infiltration was detected and more extensive demyelination and neurite loss in the cortical grey matter was found in cases exhibiting an increased level of meningeal inflammation. However, no tertiary lymphoid-like structures were found. Profound microglial activation and reduction in neuronal density was observed in both the lesions and normal appearing grey matter compared with control cortex. Furthermore, cases with primary progressive multiple sclerosis with extensive meningeal immune cell infiltration exhibited a more severe clinical course, including a shorter disease duration and younger age at death. Our data suggest that generalized diffuse meningeal inflammation and the associated inflammatory milieu in the subarachnoid compartment plays a role in the pathogenesis of cortical grey matter lesions and an increased rate of clinical progression in primary progressive multiple sclerosis.

Entities:  

Mesh:

Year:  2012        PMID: 22907116     DOI: 10.1093/brain/aws189

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  98 in total

1.  White and gray matter damage in primary progressive MS: The chicken or the egg?

Authors:  Benedetta Bodini; Declan Chard; Daniel R Altmann; Daniel Tozer; David H Miller; Alan J Thompson; Claudia Wheeler-Kingshott; Olga Ciccarelli
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

Review 2.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

3.  Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.

Authors:  S N Jonas; I Izbudak; A A Frazier; D M Harrison
Journal:  AJNR Am J Neuroradiol       Date:  2018-09-13       Impact factor: 3.825

Review 4.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

5.  Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Authors:  Sungpil Han; Yen Chih Lin; Tianxia Wu; Alan D Salgado; Ina Mexhitaj; Simone C Wuest; Elena Romm; Joan Ohayon; Raphaela Goldbach-Mansky; Adeline Vanderver; Adriana Marques; Camilo Toro; Peter Williamson; Irene Cortese; Bibiana Bielekova
Journal:  J Immunol       Date:  2014-02-07       Impact factor: 5.422

Review 6.  Isoniazid in autoimmunity: a trigger for multiple sclerosis?

Authors:  Bardia Nourbakhsh; Olaf Stüve
Journal:  Ther Adv Neurol Disord       Date:  2014-09       Impact factor: 6.570

7.  Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.

Authors:  E S Beck; P Sati; V Sethi; T Kober; B Dewey; P Bhargava; G Nair; I C Cortese; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2018-02-08       Impact factor: 3.825

8.  No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.

Authors:  Mehrnaz Ighani; Samuel Jonas; Izlem Izbudak; Seongjin Choi; Alfonso Lema-Dopico; Jun Hua; Erin E O'Connor; Daniel M Harrison
Journal:  Mult Scler       Date:  2019-10-01       Impact factor: 6.312

Review 9.  Immunopathology of multiple sclerosis.

Authors:  Calliope A Dendrou; Lars Fugger; Manuel A Friese
Journal:  Nat Rev Immunol       Date:  2015-08-07       Impact factor: 53.106

Review 10.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.